1308 related articles for article (PubMed ID: 19422256)
1. Tuning the magnetic resonance imaging properties of positive contrast agent nanoparticles by surface modification with RAFT polymers.
Rowe MD; Chang CC; Thamm DH; Kraft SL; Harmon JF; Vogt AP; Sumerlin BS; Boyes SG
Langmuir; 2009 Aug; 25(16):9487-99. PubMed ID: 19422256
[TBL] [Abstract][Full Text] [Related]
2. Polymer-modified gadolinium metal-organic framework nanoparticles used as multifunctional nanomedicines for the targeted imaging and treatment of cancer.
Rowe MD; Thamm DH; Kraft SL; Boyes SG
Biomacromolecules; 2009 Apr; 10(4):983-93. PubMed ID: 19290624
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of gadolinium nanoscale metal-organic framework with hydrotropes: manipulation of particle size and magnetic resonance imaging capability.
Hatakeyama W; Sanchez TJ; Rowe MD; Serkova NJ; Liberatore MW; Boyes SG
ACS Appl Mater Interfaces; 2011 May; 3(5):1502-10. PubMed ID: 21456529
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and characterization of PEGylated Gd2O3 nanoparticles for MRI contrast enhancement.
Ahrén M; Selegård L; Klasson A; Söderlind F; Abrikossova N; Skoglund C; Bengtsson T; Engström M; Käll PO; Uvdal K
Langmuir; 2010 Apr; 26(8):5753-62. PubMed ID: 20334417
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of relaxivity rates of Gd-DTPA complexes by intercalation into layered double hydroxide nanoparticles.
Xu ZP; Kurniawan ND; Bartlett PF; Lu GQ
Chemistry; 2007; 13(10):2824-30. PubMed ID: 17186555
[TBL] [Abstract][Full Text] [Related]
6. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.
Chen Z; Yu D; Liu C; Yang X; Zhang N; Ma C; Song J; Lu Z
J Drug Target; 2011 Sep; 19(8):657-65. PubMed ID: 21091273
[TBL] [Abstract][Full Text] [Related]
7. Comparison of a tartaric acid derived polymeric MRI contrast agent to a small molecule model chelate.
Lucas RL; Benjamin M; Reineke TM
Bioconjug Chem; 2008 Jan; 19(1):24-7. PubMed ID: 18092744
[TBL] [Abstract][Full Text] [Related]
8. Properties evaluation of a new MRI contrast agent based on Gd-loaded nanoparticles.
Riyahi-Alam N; Behrouzkia Z; Seifalian A; Haghgoo Jahromi S
Biol Trace Elem Res; 2010 Dec; 137(3):324-34. PubMed ID: 20049554
[TBL] [Abstract][Full Text] [Related]
9. Paramagnetic ultrasmall gadolinium oxide nanoparticles as advanced T1 MRI contrast agent: account for large longitudinal relaxivity, optimal particle diameter, and in vivo T1 MR images.
Park JY; Baek MJ; Choi ES; Woo S; Kim JH; Kim TJ; Jung JC; Chae KS; Chang Y; Lee GH
ACS Nano; 2009 Nov; 3(11):3663-9. PubMed ID: 19835389
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and characterization of poly(L-glutamic acid) gadolinium chelate: a new biodegradable MRI contrast agent.
Wen X; Jackson EF; Price RE; Kim EE; Wu Q; Wallace S; Charnsangavej C; Gelovani JG; Li C
Bioconjug Chem; 2004; 15(6):1408-15. PubMed ID: 15546209
[TBL] [Abstract][Full Text] [Related]
11. Cyano-bridged coordination polymer nanoparticles with high nuclear relaxivity: toward new contrast agents for MRI.
Guari Y; Larionova J; Corti M; Lascialfari A; Marinone M; Poletti G; Molvinger K; Guérin C
Dalton Trans; 2008 Jul; (28):3658-60. PubMed ID: 18615211
[TBL] [Abstract][Full Text] [Related]
12. Gd-functionalised Au nanoparticles as targeted contrast agents in MRI: relaxivity enhancement by polyelectrolyte coating.
Warsi MF; Adams RW; Duckett SB; Chechik V
Chem Commun (Camb); 2010 Jan; 46(3):451-3. PubMed ID: 20066322
[TBL] [Abstract][Full Text] [Related]
13. A novel cholic acid-based contrast enhancement agent for targeted MRI.
Chong HS; Song HA; Lim S; Macrenaris K; Ma X; Lee H; Bui P; Meade T
Bioorg Med Chem Lett; 2008 Apr; 18(7):2505-8. PubMed ID: 18337094
[TBL] [Abstract][Full Text] [Related]
14. Polymeric gadolinium chelate magnetic resonance imaging contrast agents: design, synthesis, and properties.
Ladd DL; Hollister R; Peng X; Wei D; Wu G; Delecki D; Snow RA; Toner JL; Kellar K; Eck J; Desai VC; Raymond G; Kinter LB; Desser TS; Rubin DL
Bioconjug Chem; 1999; 10(3):361-70. PubMed ID: 10346865
[TBL] [Abstract][Full Text] [Related]
15. Modulation of the surface charge on polymer-stabilized gold nanoparticles by the application of an external stimulus.
Boyer C; Whittaker MR; Chuah K; Liu J; Davis TP
Langmuir; 2010 Feb; 26(4):2721-30. PubMed ID: 19894684
[TBL] [Abstract][Full Text] [Related]
16. Surface modification of gadolinium oxide thin films and nanoparticles using poly(ethylene glycol)-phosphate.
Guay-Bégin AA; Chevallier P; Faucher L; Turgeon S; Fortin MA
Langmuir; 2012 Jan; 28(1):774-82. PubMed ID: 21970413
[TBL] [Abstract][Full Text] [Related]
17. A Gd3+-based magnetic resonance imaging contrast agent sensitive to beta-galactosidase activity utilizing a receptor-induced magnetization enhancement (RIME) phenomenon.
Hanaoka K; Kikuchi K; Terai T; Komatsu T; Nagano T
Chemistry; 2008; 14(3):987-95. PubMed ID: 17992679
[TBL] [Abstract][Full Text] [Related]
18. A polymeric micelle MRI contrast agent with changeable relaxivity.
Nakamura E; Makino K; Okano T; Yamamoto T; Yokoyama M
J Control Release; 2006 Sep; 114(3):325-33. PubMed ID: 16891027
[TBL] [Abstract][Full Text] [Related]
19. A chemical strategy for the relaxivity enhancement of Gd(III) chelates anchored on mesoporous silica nanoparticles.
Carniato F; Tei L; Cossi M; Marchese L; Botta M
Chemistry; 2010 Sep; 16(35):10727-34. PubMed ID: 20669190
[TBL] [Abstract][Full Text] [Related]
20. Surface Modification of Gd Nanoparticles with pH-Responsive Block Copolymers for Use As Smart MRI Contrast Agents.
Zhu L; Yang Y; Farquhar K; Wang J; Tian C; Ranville J; Boyes SG
ACS Appl Mater Interfaces; 2016 Feb; 8(7):5040-50. PubMed ID: 26790986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
